Green Tea Extract for Endometriosis Treatment

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of the study is to evaluate the efficacy and safety of green tea in endometriosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese University of Hong Kong
• Collaborators: Chinese Academy of Medical Sciences; Guangdong Provincial Hospital of Traditional Chinese Medicine; Jiangxi University of Traditional Chinese Medicine; Sun Yat-sen University

Criteria

Inclusion Criteria:

• Complaints of pelvic pain, dysmenorrhoea and/or dyspareunia ≥ 6 months; and

• Verbal pain rating scale > 4/10 and visual analogue pain scale > 4cm; and

• Ultrasound confirmed endometrioma with or without fibroid and adenomyoma; and

• Planned surgery treatment within 4-6 months

Exclusion Criteria:

• Age < 20 years beyond or >40 year behind the active reproductive age; or

• BMI <18.5 kg/m2 as underweight or >25 kg/m2 as overweight; or

• Chronic pelvic pain or low back pain due to other medical conditions, e.g. urological disorders and orthopaedic disorders; or

• Secondary dysmenorrhoea due to gynaecological conditions other than endometriosis, e.g. pelvic inflammatory diseases, genitourinary infections, gynaecological tumours, etc.; or

• Primary dysmenorrhoea without any underlying disease identified; or

• Ultrasound suggested polycystic ovary, haemorrhagic ovarian cyst, ovarian dermoid cyst, cystic neoplasm, tubo-ovarian abscess or other ovarian pathologies in the same ovary; or

• Chronic medical conditions under long-term medications; or

• Endometriosis under active medication in past 1 month; or

• History of herbal medicine intake in past 1 month